𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The safety profile of infliximab for Crohn's disease in clinical practice: The Mayo clinic experience in 500 patients

✍ Scribed by Jean F. Colombel; Edward V. Loftus Jr.; William J. Tremaine; Lawrence J. Egan; William S. Harmsen; Cathy D. Schleck; Alan R. Zinsmeister; William J. Sandborn

Book ID
119426896
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
180 KB
Volume
124
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adalimumab for Crohn's disease in clinic
Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients
✍ Jason M. Swoger; Edward V. Loftus Jr.; William J. Tremaine; William A. Faubion; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

## Background: We sought to assess the effectiveness and safety of adalimumab for the treatment of Crohn's disease (CD) in clinical practice. Methods: Demographic, clinical, and treatment data were abstracted from the medical record. The primary outcome was clinical response to induction therapy